People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Other, Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lobos Parent, Inc. | — | Other | Growth/Late | $1.2B | $1.3B | 2021 |
| WC SACD Holdings, Inc. | — | Other | Series D+ | $624.2M | $1.2B | 2025 |
| Aura Group, Inc. | — | Other Technology | Series D+ | $227.0M | $370.4M | 2021 |
| CYREN Ltd. | — | Other Technology | Series B | $52.0M | $206.5M | 2020 |
| NGV Parent Holdings, Inc. | — | Other | Series B | $16.5M | $274.1M | 2017 |
| X-Cor Therapeutics Inc. | — | Pharma | Pre-Seed | $200K | $9.5M | 2019 |
Brian Chang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Chang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SAMEER GANDHI | 2 | 17 |
| Bruce Lev | 2 | 7 |
| Chandler Reedy | 2 | 5 |
| Hari Ravichandran | 2 | 4 |
| Trevor Oelschig | 2 | 4 |
| Vishnu Menon | 2 | 4 |
| Jeffrey Katzenberg | 2 | 4 |
| Sujay Jaswa | 2 | 3 |
| Blake Cunneen | 2 | 3 |
| Thomas Hetherington | 2 | 2 |
| Nicholas Smith Wang | 2 | 2 |
| James Hamilton | 1 | 8 |
| John Becker | 1 | 7 |
| Bruce Johnson | 1 | 7 |
| Cary Davis | 1 | 5 |
| Brett Jackson | 1 | 5 |
| Stephen Bailey | 1 | 4 |
| Brian Dunn | 1 | 4 |
| Todd Thomson | 1 | 4 |
| Michael Ramich | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.